Although the roles of genes such as UCN, SYT4, CBLN1, CBLN2, and GLYATL1 in CRC remain unclear, our findings suggest that they can still serve as potential biomarkers for CRC prognosis. This evidence concerns the gene GLYATL1 and colorectal carcinoma.